FDA Inspection 1267851 — Daniel Gaudet
The FDA completed an inspection of Daniel Gaudet on April 9, 2025 in Chicoutimi. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 9, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chicoutimi (Canada)
Additional Details
Clinical Investigator (CI)